Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

计划入组 30 人 · 首次发布于 2023 年 12 月 5 日

Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors

计划入组 34 人 · 首次发布于 2023 年 6 月 23 日

Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

计划入组 54 人 · 首次发布于 2023 年 6 月 23 日

Personalized mRNA Tumor Vaccine

CSF-470

Tumor Cell Vaccines(NCI)

Stiftung Swiss Tumor Institute

Switzerland

VBI Vaccines Inc

Canada

National Center for Tumor Diseases

Germany

Everest Medicines Advances mRNA Tumor Vaccine Pipeline Amidst Financial Growth

mRNA Cancer Vaccines: Recent Advances and Future Directions in Immunotherapy

mRNA Cancer Vaccines Show Promise in Clinical Trials, First Approval Expected by 2029